Clinical Trial Update: Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy [Phase 3]

View source ↗

Summary

This update reports on a Phase 3 trial of amifostine in patients with ovarian epithelial cancer undergoing chemotherapy; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• ETHYOL (Amifostine)

Snippet

Sponsor: Northwestern University | Conditions: Ovarian Cancer, Quality of Life | Phase 3 | Status: COMPLETED